Most women encounter MOTS-C through PCOS content — it's the mitochondrial peptide that improves insulin sensitivity, relevant to the metabolic dysfunction at the root of PCOS/PMOS. But MOTS-C's biology extends well beyond insulin signaling, and its broader applications are particularly relevant to women as they move through midlife.
What MOTS-C actually is
MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) is a 16-amino-acid peptide encoded by mitochondrial DNA — not nuclear DNA. This is significant because mitochondria are inherited exclusively from your mother. MOTS-C is one of several "mitochondria-derived peptides" that communicate between mitochondria and the nucleus, influencing cellular metabolism and stress responses.
Discovered in 2015 by a team at USC led by Dr. Changhan David Lee, MOTS-C has been called an "exercise mimetic" because it activates AMPK — the same master metabolic switch that exercise triggers — without the physical exertion. This is an oversimplification, but the metabolic pathways are genuinely shared.
Beyond insulin: the four MOTS-C mechanisms
1. Bone formation
MOTS-C promotes osteoblast differentiation (bone-building cell activation) and inhibits osteoclast activity (bone-breaking cell activation). In women, bone density accelerates its decline after menopause — 80% of osteoporosis patients are women. A peptide that shifts the bone remodeling balance toward formation is mechanistically valuable for this population.
Animal studies show MOTS-C supplementation prevented bone loss in ovariectomized mice — a standard model for postmenopausal osteoporosis. The effect was dose-dependent and accompanied by improvements in bone mineral density, trabecular architecture, and mechanical strength.
2. Exercise mimicry and metabolic flexibility
MOTS-C activates AMPK, which triggers glucose uptake independent of insulin, increases fatty acid oxidation, and improves metabolic flexibility — the ability to switch between fuel sources (glucose and fat) based on energy demands. Metabolic inflexibility is a hallmark of insulin resistance, obesity, and the metabolic changes of menopause.
For women who are unable to exercise due to injury, disability, or severe fatigue, MOTS-C's exercise-mimetic properties represent a way to activate some of the metabolic adaptations exercise would provide. This doesn't replace exercise — but it may partially bridge the gap.
3. Cellular stress response
MOTS-C translocates to the nucleus during metabolic stress, where it directly influences gene expression related to cellular defense and adaptation. This stress-response function is distinct from its AMPK activation and represents a communication pathway between mitochondria and nuclear DNA that may be relevant to aging and cellular resilience.
4. Aging and longevity
MOTS-C levels decline with age. Centenarians have been found to carry a MOTS-C variant associated with preserved metabolic function and longevity. Whether exogenous MOTS-C supplementation can replicate the effects of a favorable genetic variant is an open question — but the association between MOTS-C levels and healthy aging is documented.
MOTS-C for women specifically
Three of MOTS-C's four primary mechanisms align with major women's health transitions:
Perimenopause and menopause: Metabolic flexibility declines as estrogen drops. MOTS-C's AMPK activation and metabolic-flexibility effects target exactly the metabolic shift that makes menopause weight gain so resistant to diet and exercise alone.
Postmenopausal bone loss: The bone-formation effects are relevant to the population most affected by osteoporosis — postmenopausal women. If MOTS-C's bone-protective effects translate from animal models to human use, it could complement existing osteoporosis treatments.
PCOS/PMOS: The insulin-sensitizing effects are the most studied application for women and the one most commonly discussed in functional medicine. MOTS-C addresses insulin resistance at the mitochondrial level — upstream of where metformin works — and may be relevant for women with PMOS whose insulin resistance doesn't respond adequately to conventional interventions.
MOTS-C is one of the most interesting peptides in the women's health landscape. Its evidence is stronger than many commonly promoted compounds and its mechanisms are directly aligned with the metabolic and skeletal transitions women face in midlife. Watch this space — the clinical data is catching up to the mechanistic promise.